Phase II clinical trial of didemnin B in patients with recurrent or refractory anaplastic astrocytoma or glioblastoma multiforme (NSC 325319). (Q40627397)
Jump to navigation
Jump to search
scientific article published on January 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II clinical trial of didemnin B in patients with recurrent or refractory anaplastic astrocytoma or glioblastoma multiforme (NSC 325319). |
scientific article published on January 1999 |
Statements
1 reference
Phase II clinical trial of didemnin B in patients with recurrent or refractory anaplastic astrocytoma or glioblastoma multiforme (NSC 325319). (English)
1 reference
Mittelman A
1 reference
Chun HG
1 reference
Puccio C
1 reference
Coombe N
1 reference
Lansen T
1 reference
Ahmed T
1 reference
1 January 1999
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference